Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-06 Sale |
2021-08-10 8:00 pm |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
25,000 | $138.52 | $3,462,926 | 132,891 (Direct) |
View |
| 2021-08-04 Sale |
2021-08-06 8:00 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $128.78 | $3,863,469 | 282,885 (Direct) |
View |
| 2021-07-19 Sale |
2021-07-21 5:21 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
10,000 | $126.43 | $1,264,348 | 498,558 (Indirect) |
View |
| 2021-06-30 Sale |
2021-07-01 5:43 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $165 | $4,125,000 | 573,007 (Direct) |
View |
| 2021-06-29 Sale |
2021-06-30 6:41 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
47,536 | $149.49 | $7,106,341 | 1,581,188 (Indirect Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 6:38 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
30,375 | $152.48 | $4,631,583 | 158,831 (Indirect Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 5:33 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $156.55 | $3,913,750 | 598,007 (Direct) |
View |
| 2021-06-21 Sale |
2021-06-23 5:54 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $128.62 | $3,215,458 | 623,007 (Direct) |
View |
| 2021-06-15 Sale |
2021-06-17 5:44 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $126.43 | $3,792,804 | 251,052 (Direct) |
View |
| 2021-06-11 Sale |
2021-06-15 4:41 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
10,000 | $126.61 | $1,266,118 | 1,575,335 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-09 Option Award |
2022-06-10 5:39 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | George Simeon Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:37 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Fardis Maria Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:36 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:35 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-24 5:55 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer |
117,750 | $0 | 117,750 (Direct) |
View |
| 2022-03-14 Tax Withholding |
2022-03-14 6:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
4,153 | $61.08 | 329,112 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-14 6:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,834 | $0 | 329,112 (Direct) |
View |
| 2022-03-11 Tax Withholding |
2022-03-14 6:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
5,487 | $62.56 | 329,112 (Direct) |
View |
| 2022-03-14 Tax Withholding |
2022-03-14 6:03 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
1,229 | $61.08 | 40,380 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-14 6:03 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
7,584 | $0 | 40,380 (Direct) |
View |
| 2022-03-11 Tax Withholding |
2022-03-14 6:03 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
1,883 | $62.56 | 40,380 (Direct) |
View |
| 2022-03-14 Tax Withholding |
2022-03-14 6:01 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
1,039 | $61.08 | 56,012 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-14 6:01 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
5,084 | $0 | 56,012 (Direct) |
View |
| 2022-03-11 Tax Withholding |
2022-03-14 6:01 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
1,321 | $62.56 | 56,012 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:44 pm |
N/A 2032-02-18 |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
45,300 | $0 | 45,300 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:43 pm |
N/A 2032-02-18 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
168,000 | $0 | 168,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:41 pm |
N/A 2032-02-18 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
66,600 | $0 | 66,600 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:40 pm |
N/A 2032-02-18 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
49,500 | $0 | 49,500 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,750 | $1.81 | 337,318 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 8:00 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,750 | $0 | 337,318 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
80,000 | $0 | 301,335 (Direct) |
View |
| 2021-12-06 Tax Withholding |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
37,818 | $69.17 | 301,335 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
26,667 | $0 | 35,658 (Direct) |
View |
| 2021-12-06 Tax Withholding |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
11,185 | $69.17 | 35,658 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
26,667 | $0 | 65,697 (Direct) |
View |
| 2021-12-06 Tax Withholding |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
12,607 | $69.17 | 65,697 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
13,333 | $0 | 50,209 (Direct) |
View |
| 2021-12-06 Tax Withholding |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
6,303 | $69.17 | 50,209 (Direct) |
View |
| 2021-12-02 Exercise |
2021-12-03 8:00 pm |
N/A 2027-05-31 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
7,342 | $0 | 130,144 (Direct) |
View |
| 2021-12-02 Exercise |
2021-12-03 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
7,342 | $13.62 | 130,144 (Direct) |
View |
| 2021-12-01 Tax Withholding |
2021-12-03 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $75.1 | 219,153 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-18 8:00 pm |
N/A 2031-10-15 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
10,800 | $0 | 10,800 (Direct) |
View |
| 2021-10-14 Option Award |
2021-10-18 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-18 8:00 pm |
N/A 2031-10-15 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
13,800 | $0 | 13,800 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-18 8:00 pm |
N/A 2031-10-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
43,000 | $0 | 338,915 (Direct) |
View |
| 2021-10-15 Exercise |
2021-10-18 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
33,000 | $1.81 | 338,915 (Direct) |
View |
| 2021-10-15 Exercise |
2021-10-18 8:00 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
33,000 | $0 | 338,915 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-18 8:00 pm |
N/A 2031-10-15 |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
13,800 | $0 | 13,800 (Direct) |
View |
| 2021-09-13 Tax Withholding |
2021-09-14 9:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
4,741 | $117.86 | 29,170 (Direct) |
View |
| 2021-09-10 Exercise |
2021-09-14 9:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
10,000 | $0 | 29,170 (Direct) |
View |
| 2021-09-10 Tax Withholding |
2021-09-14 9:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
10,000 | $0 | 6,843 (Direct) |
View |
| 2021-09-13 Tax Withholding |
2021-09-14 9:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
4,207 | $117.86 | 6,843 (Direct) |
View |
| 2021-09-10 Exercise |
2021-09-14 9:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
10,000 | $0 | 6,843 (Direct) |
View |
| 2021-09-01 Tax Withholding |
2021-09-03 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
787 | $124.83 | 186,932 (Direct) |
View |
| 2021-03-11 Exercise |
2021-08-10 8:00 pm |
N/A 2027-11-21 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
25,000 | $0 | 132,891 (Direct) |
View |
| 2021-08-06 Exercise |
2021-08-10 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
25,000 | $17.75 | 132,891 (Direct) |
View |
| 2021-08-04 Exercise |
2021-08-06 8:00 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $0 | 282,885 (Direct) |
View |
| 2021-08-04 Exercise |
2021-08-06 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $12.57 | 282,885 (Direct) |
View |
| 2021-06-28 Other |
2021-06-30 6:41 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
1,416,648 | $0 | 1,581,188 (Indirect) |
View |
| 2021-06-15 Exercise |
2021-06-17 5:44 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $0 | 251,052 (Direct) |
View |
| 2021-06-15 Exercise |
2021-06-17 5:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $12.57 | 251,052 (Direct) |
View |